Govt issues licenses to 5 more companies for production of Liposomal Amphotericin B injections to deal with Mucormycosis

May 27, 2021
2:01PM

Govt issues licenses to 5 more companies for production of Liposomal Amphotericin B injections to deal with Mucormycosis

FILE PIC
Union Government is doing everything possible to increase availability of Liposomal Amphotericin B injections to deal with Mucormycosis. To augment production, the Government has given licenses to five more companies that can make this drug. Prime Minister Narendra Modi had instructed officials to get this drug from anywhere it is available in the world.
 
AIR correspondent reports, Indian missions across the world have been involved in securing supplies of this drug. It has been achieved with help of Gilead Sciences in USA. Gilead Sciences is working on expediting the supply of AmBisome to India through Mylan. Over 121,000 vials have so far reached India. Another 85,000 vials are on the way. The company is likely to supply one million doses of AmBisome to India through Mylan. 

Popular posts from this blog

30 security personnel killed in a car bomb blast in Ghazni province in Afghanistan

11 per cent GDP growth projected by Economic Survey 2020-21 for next financial year

Pradhan Mantri Fasal Bima Yojana completes 5 years; govt urges farming community to take advantage of scheme